PATRICIA MCDONALD: Open Payments
NPI 1629142112 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $276 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $127 |
| SI-BONE, INC. | 1 | $72 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $68 |
| Amgen Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $44 |
| Lilly USA, LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: Veozah, KRYSTEXXA, QULIPTA, KISUNLA, SHINGRIX, FARXIGA, Wegovy, LEQVIO.
Industry payments across NV — which companies pay providers there.
